C. Parker

Statistics

Publications

Citations

113

H-Index

Active since

2011

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

C. Parker is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, biomarker-based efficacy assessment, and biomarkers in urologic oncology.

Publications per year

2011–2011

Publications

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.

Howard I. Scher, Glenn Heller, Ana M. Molina et al. · Journal of Clinical Oncology · 2011 · 113 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1